Covid-19 Impact on Global OTC Cough, Cold & Allergy Medicine Market Size, Status and Forecast 2020-2026

Covid-19 Impact on Global OTC Cough, Cold & Allergy Medicine Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by OTC Cough, Cold & Allergy Medicine Revenue
1.4 Covid-19 Implications on Market by Type
1.4.1 Global OTC Cough, Cold & Allergy Medicine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tablet
1.4.3 Solution
1.4.4 Drops
1.4.5 Capsule
1.4.6 Granules
1.4.7 Syrup
1.4.8 Pills
1.5 Market by Application
1.5.1 Global OTC Cough, Cold & Allergy Medicine Market Share by Application: 2020 VS 2026
1.5.2 Baby
1.5.3 Toddler
1.5.4 Preschool Children
1.5.5 School-age Children
1.5.6 Adult
1.6 Coronavirus Disease 2019 (Covid-19): OTC Cough, Cold & Allergy Medicine Industry Impact
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Covid-19 Implications on Global OTC Cough, Cold & Allergy Medicine Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global OTC Cough, Cold & Allergy Medicine Growth Trends by Regions
2.2.1 OTC Cough, Cold & Allergy Medicine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 OTC Cough, Cold & Allergy Medicine Historic Market Share by Regions (2015-2020)
2.2.3 OTC Cough, Cold & Allergy Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 OTC Cough, Cold & Allergy Medicine Market Growth Strategy
2.3.6 Primary Interviews with Key OTC Cough, Cold & Allergy Medicine Players (Opinion Leaders)
3 Covid-19 Implications on Competition Landscape by Key Players
3.1 Global Top OTC Cough, Cold & Allergy Medicine Players by Market Size
3.1.1 Global Top OTC Cough, Cold & Allergy Medicine Players by Revenue (2015-2020)
3.1.2 Global OTC Cough, Cold & Allergy Medicine Revenue Market Share by Players (2015-2020)
3.1.3 Global OTC Cough, Cold & Allergy Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global OTC Cough, Cold & Allergy Medicine Market Concentration Ratio
3.2.1 Global OTC Cough, Cold & Allergy Medicine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by OTC Cough, Cold & Allergy Medicine Revenue in 2019
3.3 OTC Cough, Cold & Allergy Medicine Key Players Head office and Area Served
3.4 Key Players OTC Cough, Cold & Allergy Medicine Product Solution and Service
3.5 Date of Enter into OTC Cough, Cold & Allergy Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Type (2015-2026)
4.1 Global OTC Cough, Cold & Allergy Medicine Historic Market Size by Type (2015-2020)
4.2 Global OTC Cough, Cold & Allergy Medicine Forecasted Market Size by Type (2021-2026)
5 Covid-19 Implications on Market Size by Application (2015-2026)
5.1 Global OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
5.2 Global OTC Cough, Cold & Allergy Medicine Forecasted Market Size by Application (2021-2026)
6 North America Impact of COVID-19
6.1 North America OTC Cough, Cold & Allergy Medicine Market Size (2015-2020)
6.2 OTC Cough, Cold & Allergy Medicine Key Players in North America (2019-2020)
6.3 North America OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020)
6.4 North America OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
7 Europe Impact of COVID-19
7.1 Europe OTC Cough, Cold & Allergy Medicine Market Size (2015-2020)
7.2 OTC Cough, Cold & Allergy Medicine Key Players in Europe (2019-2020)
7.3 Europe OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020)
7.4 Europe OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
8 China Impact of COVID-19
8.1 China OTC Cough, Cold & Allergy Medicine Market Size (2015-2020)
8.2 OTC Cough, Cold & Allergy Medicine Key Players in China (2019-2020)
8.3 China OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020)
8.4 China OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
9 Japan Impact of COVID-19
9.1 Japan OTC Cough, Cold & Allergy Medicine Market Size (2015-2020)
9.2 OTC Cough, Cold & Allergy Medicine Key Players in Japan (2019-2020)
9.3 Japan OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020)
9.4 Japan OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
10 Southeast Asia Impact of COVID-19
10.1 Southeast Asia OTC Cough, Cold & Allergy Medicine Market Size (2015-2020)
10.2 OTC Cough, Cold & Allergy Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
11 India Impact of COVID-19
11.1 India OTC Cough, Cold & Allergy Medicine Market Size (2015-2020)
11.2 OTC Cough, Cold & Allergy Medicine Key Players in India (2019-2020)
11.3 India OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020)
11.4 India OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
12 Central & South America Impact of COVID-19
12.1 Central & South America OTC Cough, Cold & Allergy Medicine Market Size (2015-2020)
12.2 OTC Cough, Cold & Allergy Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020)
12.4 Central & South America OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Sanofi-Aventis
13.1.1 Sanofi-Aventis Company Details
13.1.2 Sanofi-Aventis Business Overview and Its Total Revenue
13.1.3 Sanofi-Aventis OTC Cough, Cold & Allergy Medicine Introduction
13.1.4 Sanofi-Aventis Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020))
13.1.5 Sanofi-Aventis Recent Development and Reaction to COVID-19
13.2 Johnson & Johnson Service
13.2.1 Johnson & Johnson Service Company Details
13.2.2 Johnson & Johnson Service Business Overview and Its Total Revenue
13.2.3 Johnson & Johnson Service OTC Cough, Cold & Allergy Medicine Introduction
13.2.4 Johnson & Johnson Service Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
13.2.5 Johnson & Johnson Service Recent Development and Reaction to COVID-19
13.3 Reckitt Benckiser Group
13.3.1 Reckitt Benckiser Group Company Details
13.3.2 Reckitt Benckiser Group Business Overview and Its Total Revenue
13.3.3 Reckitt Benckiser Group OTC Cough, Cold & Allergy Medicine Introduction
13.3.4 Reckitt Benckiser Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
13.3.5 Reckitt Benckiser Group Recent Development and Reaction to COVID-19
13.4 Novartis AG
13.4.1 Novartis AG Company Details
13.4.2 Novartis AG Business Overview and Its Total Revenue
13.4.3 Novartis AG OTC Cough, Cold & Allergy Medicine Introduction
13.4.4 Novartis AG Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
13.4.5 Novartis AG Recent Development and Reaction to COVID-19
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.5.3 GlaxoSmithKline OTC Cough, Cold & Allergy Medicine Introduction
13.5.4 GlaxoSmithKline Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development and Reaction to COVID-19
13.6 AstraZaneca
13.6.1 AstraZaneca Company Details
13.6.2 AstraZaneca Business Overview and Its Total Revenue
13.6.3 AstraZaneca OTC Cough, Cold & Allergy Medicine Introduction
13.6.4 AstraZaneca Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
13.6.5 AstraZaneca Recent Development and Reaction to COVID-19
13.7 Pfizer Inc.
13.7.1 Pfizer Inc. Company Details
13.7.2 Pfizer Inc. Business Overview and Its Total Revenue
13.7.3 Pfizer Inc. OTC Cough, Cold & Allergy Medicine Introduction
13.7.4 Pfizer Inc. Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
13.7.5 Pfizer Inc. Recent Development and Reaction to COVID-19
13.8 Sun Pharmaceutical Industries
13.8.1 Sun Pharmaceutical Industries Company Details
13.8.2 Sun Pharmaceutical Industries Business Overview and Its Total Revenue
13.8.3 Sun Pharmaceutical Industries OTC Cough, Cold & Allergy Medicine Introduction
13.8.4 Sun Pharmaceutical Industries Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
13.8.5 Sun Pharmaceutical Industries Recent Development and Reaction to COVID-19
13.9 Prestige Brands Holdings
13.9.1 Prestige Brands Holdings Company Details
13.9.2 Prestige Brands Holdings Business Overview and Its Total Revenue
13.9.3 Prestige Brands Holdings OTC Cough, Cold & Allergy Medicine Introduction
13.9.4 Prestige Brands Holdings Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
13.9.5 Prestige Brands Holdings Recent Development and Reaction to COVID-19
13.10 Procter & Gamble
13.10.1 Procter & Gamble Company Details
13.10.2 Procter & Gamble Business Overview and Its Total Revenue
13.10.3 Procter & Gamble OTC Cough, Cold & Allergy Medicine Introduction
13.10.4 Procter & Gamble Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
13.10.5 Procter & Gamble Recent Development and Reaction to COVID-19
13.11 Bristol-Myers Squib
10.11.1 Bristol-Myers Squib Company Details
10.11.2 Bristol-Myers Squib Business Overview and Its Total Revenue
10.11.3 Bristol-Myers Squib OTC Cough, Cold & Allergy Medicine Introduction
10.11.4 Bristol-Myers Squib Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.11.5 Bristol-Myers Squib Recent Development and Reaction to COVID-19
13.12 Merck
10.12.1 Merck Company Details
10.12.2 Merck Business Overview and Its Total Revenue
10.12.3 Merck OTC Cough, Cold & Allergy Medicine Introduction
10.12.4 Merck Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.12.5 Merck Recent Development and Reaction to COVID-19
13.13 Allergen
10.13.1 Allergen Company Details
10.13.2 Allergen Business Overview and Its Total Revenue
10.13.3 Allergen OTC Cough, Cold & Allergy Medicine Introduction
10.13.4 Allergen Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.13.5 Allergen Recent Development and Reaction to COVID-19
13.14 Toray Industries
10.14.1 Toray Industries Company Details
10.14.2 Toray Industries Business Overview and Its Total Revenue
10.14.3 Toray Industries OTC Cough, Cold & Allergy Medicine Introduction
10.14.4 Toray Industries Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.14.5 Toray Industries Recent Development and Reaction to COVID-19
13.15 Beijing Tongrentang
10.15.1 Beijing Tongrentang Company Details
10.15.2 Beijing Tongrentang Business Overview and Its Total Revenue
10.15.3 Beijing Tongrentang OTC Cough, Cold & Allergy Medicine Introduction
10.15.4 Beijing Tongrentang Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.15.5 Beijing Tongrentang Recent Development and Reaction to COVID-19
13.16 Essence Pharmaceutical Group
10.16.1 Essence Pharmaceutical Group Company Details
10.16.2 Essence Pharmaceutical Group Business Overview and Its Total Revenue
10.16.3 Essence Pharmaceutical Group OTC Cough, Cold & Allergy Medicine Introduction
10.16.4 Essence Pharmaceutical Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.16.5 Essence Pharmaceutical Group Recent Development and Reaction to COVID-19
13.17 Jiangxi Heying Pharmaceutical
10.17.1 Jiangxi Heying Pharmaceutical Company Details
10.17.2 Jiangxi Heying Pharmaceutical Business Overview and Its Total Revenue
10.17.3 Jiangxi Heying Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
10.17.4 Jiangxi Heying Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.17.5 Jiangxi Heying Pharmaceutical Recent Development and Reaction to COVID-19
13.18 Diao Group Chengdu Pharmaceutical
10.18.1 Diao Group Chengdu Pharmaceutical Company Details
10.18.2 Diao Group Chengdu Pharmaceutical Business Overview and Its Total Revenue
10.18.3 Diao Group Chengdu Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
10.18.4 Diao Group Chengdu Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.18.5 Diao Group Chengdu Pharmaceutical Recent Development and Reaction to COVID-19
13.19 Shanghai Pharmaceutical
10.19.1 Shanghai Pharmaceutical Company Details
10.19.2 Shanghai Pharmaceutical Business Overview and Its Total Revenue
10.19.3 Shanghai Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
10.19.4 Shanghai Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.19.5 Shanghai Pharmaceutical Recent Development and Reaction to COVID-19
13.20 Harbin Children's Pharmaceutical
10.20.1 Harbin Children's Pharmaceutical Company Details
10.20.2 Harbin Children's Pharmaceutical Business Overview and Its Total Revenue
10.20.3 Harbin Children's Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
10.20.4 Harbin Children's Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.20.5 Harbin Children's Pharmaceutical Recent Development and Reaction to COVID-19
13.21 China Resources Sanjiu Pharmaceutical
10.21.1 China Resources Sanjiu Pharmaceutical Company Details
10.21.2 China Resources Sanjiu Pharmaceutical Business Overview and Its Total Revenue
10.21.3 China Resources Sanjiu Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
10.21.4 China Resources Sanjiu Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.21.5 China Resources Sanjiu Pharmaceutical Recent Development and Reaction to COVID-19
13.22 Xinjiang Quanan Pharmaceutical
10.22.1 Xinjiang Quanan Pharmaceutical Company Details
10.22.2 Xinjiang Quanan Pharmaceutical Business Overview and Its Total Revenue
10.22.3 Xinjiang Quanan Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
10.22.4 Xinjiang Quanan Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.22.5 Xinjiang Quanan Pharmaceutical Recent Development and Reaction to COVID-19
13.23 Jiangsu Huayang Pharmaceutical
10.23.1 Jiangsu Huayang Pharmaceutical Company Details
10.23.2 Jiangsu Huayang Pharmaceutical Business Overview and Its Total Revenue
10.23.3 Jiangsu Huayang Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
10.23.4 Jiangsu Huayang Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.23.5 Jiangsu Huayang Pharmaceutical Recent Development and Reaction to COVID-19
13.24 Nanjing Chengong Pharmaceutical
10.24.1 Nanjing Chengong Pharmaceutical Company Details
10.24.2 Nanjing Chengong Pharmaceutical Business Overview and Its Total Revenue
10.24.3 Nanjing Chengong Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
10.24.4 Nanjing Chengong Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.24.5 Nanjing Chengong Pharmaceutical Recent Development and Reaction to COVID-19
13.25 Beijing Jiulong Pharmaceutical
10.25.1 Beijing Jiulong Pharmaceutical Company Details
10.25.2 Beijing Jiulong Pharmaceutical Business Overview and Its Total Revenue
10.25.3 Beijing Jiulong Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
10.25.4 Beijing Jiulong Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.25.5 Beijing Jiulong Pharmaceutical Recent Development and Reaction to COVID-19
13.26 Livzon Group
10.26.1 Livzon Group Company Details
10.26.2 Livzon Group Business Overview and Its Total Revenue
10.26.3 Livzon Group OTC Cough, Cold & Allergy Medicine Introduction
10.26.4 Livzon Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.26.5 Livzon Group Recent Development and Reaction to COVID-19
13.27 Sinopharm Group
10.27.1 Sinopharm Group Company Details
10.27.2 Sinopharm Group Business Overview and Its Total Revenue
10.27.3 Sinopharm Group OTC Cough, Cold & Allergy Medicine Introduction
10.27.4 Sinopharm Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.27.5 Sinopharm Group Recent Development and Reaction to COVID-19
13.28 CSPC
10.28.1 CSPC Company Details
10.28.2 CSPC Business Overview and Its Total Revenue
10.28.3 CSPC OTC Cough, Cold & Allergy Medicine Introduction
10.28.4 CSPC Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
10.28.5 CSPC Recent Development and Reaction to COVID-19
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. OTC Cough, Cold & Allergy Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by OTC Cough, Cold & Allergy Medicine Revenue
Table 3. Ranking of Global Top OTC Cough, Cold & Allergy Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global OTC Cough, Cold & Allergy Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tablet
Table 6. Key Players of Solution
Table 7. Key Players of Drops
Table 8. Key Players of Capsule
Table 9. Key Players of Granules
Table 10. Key Players of Syrup
Table 11. Key Players of Pills
Table 12. COVID-19 Impact Global Market: (Four OTC Cough, Cold & Allergy Medicine Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for OTC Cough, Cold & Allergy Medicine Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for OTC Cough, Cold & Allergy Medicine Players to Combat Covid-19 Impact
Table 17. Global OTC Cough, Cold & Allergy Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 18. Global OTC Cough, Cold & Allergy Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 19. Global OTC Cough, Cold & Allergy Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 20. Global OTC Cough, Cold & Allergy Medicine Market Share by Regions (2015-2020)
Table 21. Global OTC Cough, Cold & Allergy Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 22. Global OTC Cough, Cold & Allergy Medicine Market Share by Regions (2021-2026)
Table 23. Market Top Trends
Table 24. Key Drivers: Impact Analysis
Table 25. Key Challenges
Table 26. OTC Cough, Cold & Allergy Medicine Market Growth Strategy
Table 27. Main Points Interviewed from Key OTC Cough, Cold & Allergy Medicine Players
Table 28. Global OTC Cough, Cold & Allergy Medicine Revenue by Players (2015-2020) (Million US$)
Table 29. Global OTC Cough, Cold & Allergy Medicine Market Share by Players (2015-2020)
Table 30. Global Top OTC Cough, Cold & Allergy Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Cough, Cold & Allergy Medicine as of 2019)
Table 31. Global OTC Cough, Cold & Allergy Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 32. Key Players Headquarters and Area Served
Table 33. Key Players OTC Cough, Cold & Allergy Medicine Product Solution and Service
Table 34. Date of Enter into OTC Cough, Cold & Allergy Medicine Market
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020) (Million US$)
Table 37. Global OTC Cough, Cold & Allergy Medicine Market Size Share by Type (2015-2020)
Table 38. Global OTC Cough, Cold & Allergy Medicine Revenue Market Share by Type (2021-2026)
Table 39. Global OTC Cough, Cold & Allergy Medicine Market Size Share by Application (2015-2020)
Table 40. Global OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020) (Million US$)
Table 41. Global OTC Cough, Cold & Allergy Medicine Market Size Share by Application (2021-2026)
Table 42. North America Key Players OTC Cough, Cold & Allergy Medicine Revenue (2019-2020) (Million US$)
Table 43. North America Key Players OTC Cough, Cold & Allergy Medicine Market Share (2019-2020)
Table 44. North America OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020) (Million US$)
Table 45. North America OTC Cough, Cold & Allergy Medicine Market Share by Type (2015-2020)
Table 46. North America OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020) (Million US$)
Table 47. North America OTC Cough, Cold & Allergy Medicine Market Share by Application (2015-2020)
Table 48. Europe Key Players OTC Cough, Cold & Allergy Medicine Revenue (2019-2020) (Million US$)
Table 49. Europe Key Players OTC Cough, Cold & Allergy Medicine Market Share (2019-2020)
Table 50. Europe OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020) (Million US$)
Table 51. Europe OTC Cough, Cold & Allergy Medicine Market Share by Type (2015-2020)
Table 52. Europe OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020) (Million US$)
Table 53. Europe OTC Cough, Cold & Allergy Medicine Market Share by Application (2015-2020)
Table 54. China Key Players OTC Cough, Cold & Allergy Medicine Revenue (2019-2020) (Million US$)
Table 55. China Key Players OTC Cough, Cold & Allergy Medicine Market Share (2019-2020)
Table 56. China OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020) (Million US$)
Table 57. China OTC Cough, Cold & Allergy Medicine Market Share by Type (2015-2020)
Table 58. China OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020) (Million US$)
Table 59. China OTC Cough, Cold & Allergy Medicine Market Share by Application (2015-2020)
Table 60. Japan Key Players OTC Cough, Cold & Allergy Medicine Revenue (2019-2020) (Million US$)
Table 61. Japan Key Players OTC Cough, Cold & Allergy Medicine Market Share (2019-2020)
Table 62. Japan OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020) (Million US$)
Table 63. Japan OTC Cough, Cold & Allergy Medicine Market Share by Type (2015-2020)
Table 64. Japan OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020) (Million US$)
Table 65. Japan OTC Cough, Cold & Allergy Medicine Market Share by Application (2015-2020)
Table 66. Southeast Asia Key Players OTC Cough, Cold & Allergy Medicine Revenue (2019-2020) (Million US$)
Table 67. Southeast Asia Key Players OTC Cough, Cold & Allergy Medicine Market Share (2019-2020)
Table 68. Southeast Asia OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020) (Million US$)
Table 69. Southeast Asia OTC Cough, Cold & Allergy Medicine Market Share by Type (2015-2020)
Table 70. Southeast Asia OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020) (Million US$)
Table 71. Southeast Asia OTC Cough, Cold & Allergy Medicine Market Share by Application (2015-2020)
Table 72. India Key Players OTC Cough, Cold & Allergy Medicine Revenue (2019-2020) (Million US$)
Table 73. India Key Players OTC Cough, Cold & Allergy Medicine Market Share (2019-2020)
Table 74. India OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020) (Million US$)
Table 75. India OTC Cough, Cold & Allergy Medicine Market Share by Type (2015-2020)
Table 76. India OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020) (Million US$)
Table 77. India OTC Cough, Cold & Allergy Medicine Market Share by Application (2015-2020)
Table 78. Central & South America Key Players OTC Cough, Cold & Allergy Medicine Revenue (2019-2020) (Million US$)
Table 79. Central & South America Key Players OTC Cough, Cold & Allergy Medicine Market Share (2019-2020)
Table 80. Central & South America OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020) (Million US$)
Table 81. Central & South America OTC Cough, Cold & Allergy Medicine Market Share by Type (2015-2020)
Table 82. Central & South America OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020) (Million US$)
Table 83. Central & South America OTC Cough, Cold & Allergy Medicine Market Share by Application (2015-2020)
Table 84. Sanofi-Aventis Company Details
Table 85. Sanofi-Aventis Business Overview
Table 86. Sanofi-Aventis Product
Table 87. Sanofi-Aventis Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 88. Sanofi-Aventis Recent Development
Table 89. Johnson & Johnson Service Company Details
Table 90. Johnson & Johnson Service Business Overview
Table 91. Johnson & Johnson Service Product
Table 92. Johnson & Johnson Service Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 93. Johnson & Johnson Service Recent Development
Table 94. Reckitt Benckiser Group Company Details
Table 95. Reckitt Benckiser Group Business Overview
Table 96. Reckitt Benckiser Group Product
Table 97. Reckitt Benckiser Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 98. Reckitt Benckiser Group Recent Development
Table 99. Novartis AG Company Details
Table 100. Novartis AG Business Overview
Table 101. Novartis AG Product
Table 102. Novartis AG Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 103. Novartis AG Recent Development
Table 104. GlaxoSmithKline Company Details
Table 105. GlaxoSmithKline Business Overview
Table 106. GlaxoSmithKline Product
Table 107. GlaxoSmithKline Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 108. GlaxoSmithKline Recent Development
Table 109. AstraZaneca Company Details
Table 110. AstraZaneca Business Overview
Table 111. AstraZaneca Product
Table 112. AstraZaneca Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 113. AstraZaneca Recent Development
Table 114. Pfizer Inc. Company Details
Table 115. Pfizer Inc. Business Overview
Table 116. Pfizer Inc. Product
Table 117. Pfizer Inc. Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 118. Pfizer Inc. Recent Development
Table 119. Sun Pharmaceutical Industries Business Overview
Table 120. Sun Pharmaceutical Industries Product
Table 121. Sun Pharmaceutical Industries Company Details
Table 122. Sun Pharmaceutical Industries Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 123. Sun Pharmaceutical Industries Recent Development
Table 124. Prestige Brands Holdings Company Details
Table 125. Prestige Brands Holdings Business Overview
Table 126. Prestige Brands Holdings Product
Table 127. Prestige Brands Holdings Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 128. Prestige Brands Holdings Recent Development
Table 129. Procter & Gamble Company Details
Table 130. Procter & Gamble Business Overview
Table 131. Procter & Gamble Product
Table 132. Procter & Gamble Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 133. Procter & Gamble Recent Development
Table 134. Bristol-Myers Squib Company Details
Table 135. Bristol-Myers Squib Business Overview
Table 136. Bristol-Myers Squib Product
Table 137. Bristol-Myers Squib Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 138. Bristol-Myers Squib Recent Development
Table 139. Merck Company Details
Table 140. Merck Business Overview
Table 141. Merck Product
Table 142. Merck Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 143. Merck Recent Development
Table 144. Allergen Company Details
Table 145. Allergen Business Overview
Table 146. Allergen Product
Table 147. Allergen Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 148. Allergen Recent Development
Table 149. Toray Industries Company Details
Table 150. Toray Industries Business Overview
Table 151. Toray Industries Product
Table 152. Toray Industries Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 153. Toray Industries Recent Development
Table 154. Beijing Tongrentang Company Details
Table 155. Beijing Tongrentang Business Overview
Table 156. Beijing Tongrentang Product
Table 157. Beijing Tongrentang Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 158. Beijing Tongrentang Recent Development
Table 159. Essence Pharmaceutical Group Company Details
Table 160. Essence Pharmaceutical Group Business Overview
Table 161. Essence Pharmaceutical Group Product
Table 162. Essence Pharmaceutical Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 163. Essence Pharmaceutical Group Recent Development
Table 164. Jiangxi Heying Pharmaceutical Company Details
Table 165. Jiangxi Heying Pharmaceutical Business Overview
Table 166. Jiangxi Heying Pharmaceutical Product
Table 167. Jiangxi Heying Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 168. Jiangxi Heying Pharmaceutical Recent Development
Table 169. Diao Group Chengdu Pharmaceutical Company Details
Table 170. Diao Group Chengdu Pharmaceutical Business Overview
Table 171. Diao Group Chengdu Pharmaceutical Product
Table 172. Diao Group Chengdu Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 173. Diao Group Chengdu Pharmaceutical Recent Development
Table 174. Shanghai Pharmaceutical Company Details
Table 175. Shanghai Pharmaceutical Business Overview
Table 176. Shanghai Pharmaceutical Product
Table 177. Shanghai Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 178. Shanghai Pharmaceutical Recent Development
Table 179. Harbin Children's Pharmaceutical Company Details
Table 180. Harbin Children's Pharmaceutical Business Overview
Table 181. Harbin Children's Pharmaceutical Product
Table 182. Harbin Children's Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 183. Harbin Children's Pharmaceutical Recent Development
Table 184. China Resources Sanjiu Pharmaceutical Company Details
Table 185. China Resources Sanjiu Pharmaceutical Business Overview
Table 186. China Resources Sanjiu Pharmaceutical Product
Table 187. China Resources Sanjiu Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 188. China Resources Sanjiu Pharmaceutical Recent Development
Table 189. Xinjiang Quanan Pharmaceutical Company Details
Table 190. Xinjiang Quanan Pharmaceutical Business Overview
Table 191. Xinjiang Quanan Pharmaceutical Product
Table 192. Xinjiang Quanan Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 193. Xinjiang Quanan Pharmaceutical Recent Development
Table 194. Jiangsu Huayang Pharmaceutical Company Details
Table 195. Jiangsu Huayang Pharmaceutical Business Overview
Table 196. Jiangsu Huayang Pharmaceutical Product
Table 197. Jiangsu Huayang Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 198. Jiangsu Huayang Pharmaceutical Recent Development
Table 199. Nanjing Chengong Pharmaceutical Company Details
Table 200. Nanjing Chengong Pharmaceutical Business Overview
Table 201. Nanjing Chengong Pharmaceutical Product
Table 202. Nanjing Chengong Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 203. Nanjing Chengong Pharmaceutical Recent Development
Table 204. Beijing Jiulong Pharmaceutical Company Details
Table 205. Beijing Jiulong Pharmaceutical Business Overview
Table 206. Beijing Jiulong Pharmaceutical Product
Table 207. Beijing Jiulong Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 208. Beijing Jiulong Pharmaceutical Recent Development
Table 209. Livzon Group Company Details
Table 210. Livzon Group Business Overview
Table 211. Livzon Group Product
Table 212. Livzon Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020) (Million US$)
Table 213. Livzon Group Recent Development
Table 214. Sinopharm Group Company Details
Table 215. Sinopharm Group Business Overview
Table 216. Sinopharm Group

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs